M09 - Moving Beyond Technology Champions: Engaging the Team in CGM Initiation and Utilization

Monday, August 11, 2025

10:00 AM – 10:45 AM MT

CE/CME Hours: .75 CE

Pharmacology Hours: 0.0 CE

Primary Presenter(s)

Katelyn Parsons, PharmD, BCACP (she/her/hers)

Clinical Associate Professor
Western New England University
Springfield, Massachusetts

Disclosure(s): Abbott: Abbott supplied Baystate Primary Care Longmeadow with Freestyle Libre 3 sensors through an Abbott Diabetes Care Educational Wear Medical Grant (Ongoing)

Co-Presenter(s)

Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM (she/her/hers)

Clinical Pharmacy Specialist
Boston Medical Center
Dorchester, Massachusetts

Disclosure(s): Bayer Pharmaceuticals: Consultant / Advisory Board (Terminated, May 6, 2023); Eli Lilly: Consultant / Advisory Board (Terminated, October 18, 2024); Sanofi: Consultant / Advisory Board (Terminated, September 27, 2024)

With the expansion of continuous glucose monitoring (CGM) technology and insurance coverage, healthcare teams need to be equipped to support patient access and effective utilization of these devices. This session reviews examples of strategies to increase knowledge and confidence with CGMs among the healthcare team from outpatient and inpatient practice settings. Speakers will discuss how the Identify, Configure, Collaborate (ICC) framework can be used to increase CGM uptake and optimize workflow by engaging various team members to improve diabetes outcomes.

Disclosure(s):

Katelyn Parsons, PharmD, BCACP: Abbott: Abbott supplied Baystate Primary Care Longmeadow with Freestyle Libre 3 sensors through an Abbott Diabetes Care Educational Wear Medical Grant (Ongoing)

Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM: Bayer Pharmaceuticals: Consultant / Advisory Board (Terminated, May 6, 2023); Eli Lilly: Consultant / Advisory Board (Terminated, October 18, 2024); Sanofi: Consultant / Advisory Board (Terminated, September 27, 2024)